Fertility Preservation in Endometriosis: Does Patient Symptomatology Affect the Extent of the Ovarian Response?
Endometrioma
Endometriosis
Fertility preservation
Symptoms of endometriosis
Journal
Reproductive sciences (Thousand Oaks, Calif.)
ISSN: 1933-7205
Titre abrégé: Reprod Sci
Pays: United States
ID NLM: 101291249
Informations de publication
Date de publication:
08 2023
08 2023
Historique:
received:
06
10
2022
accepted:
24
01
2023
medline:
21
7
2023
pubmed:
15
2
2023
entrez:
14
2
2023
Statut:
ppublish
Résumé
This study is to identify factors and patient symptomatology affecting ovarian response in women with endometriosis who seek fertility preservation. An observational cross-sectional study was conducted from July 2017 to May 2020 at a tertiary university-affiliated medical center. We included patients who were treated in the endometriosis clinic and underwent fertility preservation. Patients completed an online questionnaire that was cross-referenced with electronic charts. An analysis related to patient data and fertility preservation cycles and a mediation analysis were performed. The mean patient age at time of fertility preservation was 35.2 (± 4.9) years. The mean accumulated number of oocytes vitrified per patient was 16.7 (± 12.1) oocytes. The correlation coefficient assessed between the number of oocytes vitrified per cycle and AMH was significantly positive at +0.472, p = 0.006. The examined reported symptoms were lethargy, chronic pelvic pain, dyschezia, dyspareunia, bowel-associated symptoms, and urinary tract symptoms. The number of oocytes vitrified correlated with the number of reported symptoms and clinical characteristics at - 0.497, p = 0.0001, and - 0.442, p = 0.0001, respectively. In a mediation analysis, the potential causality of surgical intervention in the relationship between the number of symptoms and ovarian response was - 0.300 (95% CI [0.15, 1.905], p = 0.05), and the calculated proportion of mediation was estimated to be 17%. We observed a significant negative association between the number of clinical symptoms and the quantity of vitrified oocytes. This relationship was only partly associated with prior surgical intervention. AMH was found to have the highest correlation with treatment success in patients with endometriosis undergoing fertility preservation.
Identifiants
pubmed: 36788174
doi: 10.1007/s43032-023-01180-5
pii: 10.1007/s43032-023-01180-5
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2439-2448Informations de copyright
© 2023. The Author(s), under exclusive licence to Society for Reproductive Investigation.
Références
Koninckx PR, Ussia A, Adamyan L, Wattiez A, Gomel V, Martin DC. Pathogenesis of endometriosis: the genetic/epigenetic theory. Fertil Steril. 2019;111(2):327–40.
doi: 10.1016/j.fertnstert.2018.10.013
pubmed: 30527836
Santulli P, Collinet P, Fritel X, Canis M, d’Argent EM, Chauffour C, et al. Management of assisted reproductive technology (ART) in case of endometriosis related infertility: CNGOF-HAS Endometriosis Guidelines. Gynecol Obstet Fertil Senol. 2018;46(3):373–5.
pubmed: 29503237
Llarena NC, Falcone T, Flyckt RL. Fertility preservation in women with endometriosis. Clin Med Insights Reprod Health. 2019;13:1179558119873386.
doi: 10.1177/1179558119873386
pubmed: 31516316
pmcid: 6724494
Evans MB, Decherney AH. Fertility and endometriosis. Clin Obstet Gynecol. 2017;60(3):497–502.
doi: 10.1097/GRF.0000000000000295
pubmed: 28742581
Lantsberg D, Fernando S, Cohen Y, Rombauts L. The role of fertility preservation in women with endometriosis: a systematic review. J Minim Invasive Gynecol. 2020;27(2):362–72.
doi: 10.1016/j.jmig.2019.09.780
pubmed: 31546067
Barri PN, Coroleu B, Tur R, Barri-Soldevila PN, Rodríguez I. Endometriosis-associated infertility: surgery and IVF, a comprehensive therapeutic approach. Reprod Biomed Online. 2010;21(2):179–85.
doi: 10.1016/j.rbmo.2010.04.026
pubmed: 20541976
Lima ML, Martins WP, Coelho Neto MA, Nastri CO, Ferriani RA, Navarro PA. Assessment of ovarian reserve by antral follicle count in ovaries with endometrioma. Ultrasound Obstet Gynecol. 2015;46(2):239–42.
doi: 10.1002/uog.14763
pubmed: 25504940
Muzii L, Di Tucci C, Di Feliciantonio M, Marchetti C, Perniola G, Panici PB. The effect of surgery for endometrioma on ovarian reserve evaluated by antral follicle count: a systematic review and meta-analysis. Hum Reprod. 2014;29(10):2190–8.
doi: 10.1093/humrep/deu199
pubmed: 25085800
Nieweglowska D, Hajdyla-Banas I, Pitynski K, Banas T, Grabowska O, Juszczyk G, et al. Age-related trends in anti-Mullerian hormone serum level in women with unilateral and bilateral ovarian endometriomas prior to surgery. Reprod Biol Endocrinol. 2015;13:128.
doi: 10.1186/s12958-015-0125-x
pubmed: 26596960
pmcid: 4657379
Ozgur K, Bulut H, Berkkanoglu M, Coetzee K. Reproductive outcomes of segmented in vitro fertilization in patients diagnosed with endometriomas. J Minim Invasive Gynecol. 2018;25(1):105–10.
doi: 10.1016/j.jmig.2017.06.030
pubmed: 28822715
Cobo A, Giles J, Paolelli S, Pellicer A, Remohí J, García-Velasco JA. Oocyte vitrification for fertility preservation in women with endometriosis: an observational study. Fertil Steril. 2020;113(4):836–44.
doi: 10.1016/j.fertnstert.2019.11.017
pubmed: 32145929
Somigliana E, Vercellini P. Fertility preservation in women with endometriosis: speculations are finally over, the time for real data is initiated. Fertil Steril. 2020;113(4):765–6.
doi: 10.1016/j.fertnstert.2019.12.020
pubmed: 32147176
Practice bulletin no. 114: management of endometriosis. Obstet Gynecol. 2010;116(1):223–36.
Chronic Pelvic Pain. ACOG Practice Bulletin, Number 218. Obstet Gynecol. 2020;135(3):e98–e109.
doi: 10.1097/AOG.0000000000003716
Agarwal SK, Chapron C, Giudice LC, Laufer MR, Leyland N, Missmer SA, et al. Clinical diagnosis of endometriosis: a call to action. Am J Obstet Gynecol. 2019;220(4):354 e1-e12.
doi: 10.1016/j.ajog.2018.12.039
Fuldeore MJ, Soliman AM. Prevalence and symptomatic burden of diagnosed endometriosis in the United States: national estimates from a cross-sectional survey of 59,411 women. Gynecol Obstet Invest. 2017;82(5):453–61.
doi: 10.1159/000452660
pubmed: 27820938
Saha R, Marions L, Tornvall P. Validity of self-reported endometriosis and endometriosis-related questions in a Swedish female twin cohort. Fertil Steril. 2017;107(1):174–8 e2.
doi: 10.1016/j.fertnstert.2016.09.038
pubmed: 27793372
Rock JA. The revised American Fertility Society classification of endometriosis: reproducibility of scoring. ZOLADEX Endometriosis Study Group. Fertil Steril. 1995;63(5):1108–10.
doi: 10.1016/S0015-0282(16)57556-6
pubmed: 7720925
de Ziegler D, Borghese B, Chapron C. Endometriosis and infertility: pathophysiology and management. Lancet. 2010;376(9742):730–8.
doi: 10.1016/S0140-6736(10)60490-4
pubmed: 20801404
Sanchez AM, Vigano P, Somigliana E, Panina-Bordignon P, Vercellini P, Candiani M. The distinguishing cellular and molecular features of the endometriotic ovarian cyst: from pathophysiology to the potential endometrioma-mediated damage to the ovary. Hum Reprod Update. 2014;20(2):217–30.
doi: 10.1093/humupd/dmt053
pubmed: 24129684
Kitajima M, Dolmans MM, Donnez O, Masuzaki H, Soares M, Donnez J. Enhanced follicular recruitment and atresia in cortex derived from ovaries with endometriomas. Fertil Steril. 2014;101(4):1031–7.
doi: 10.1016/j.fertnstert.2013.12.049
pubmed: 24502890
Carrillo L, Seidman DS, Cittadini E, Meirow D. The role of fertility preservation in patients with endometriosis. J Assist Reprod Genet. 2016;33(3):317–23.
doi: 10.1007/s10815-016-0646-z
pubmed: 26768141
pmcid: 4785156
Younis JS, Shapso N, Fleming R, Ben-Shlomo I, Izhaki I. Impact of unilateral versus bilateral ovarian endometriotic cystectomy on ovarian reserve: a systematic review and meta-analysis. Hum Reprod Update. 2019;25(3):375–91.
doi: 10.1093/humupd/dmy049
pubmed: 30715359
Hirokawa W, Iwase A, Goto M, Takikawa S, Nagatomo Y, Nakahara T, et al. The post-operative decline in serum anti-Mullerian hormone correlates with the bilaterality and severity of endometriosis. Hum Reprod. 2011;26(4):904–10.
doi: 10.1093/humrep/der006
pubmed: 21292639
Haas D, Shebl O, Shamiyeh A, Oppelt P. The rASRM score and the Enzian classification for endometriosis: their strengths and weaknesses. Acta Obstet Gynecol Scand. 2013;92(1):3–7.
doi: 10.1111/aogs.12026
pubmed: 23061819
Schliep KC, Mumford SL, Peterson CM, Chen Z, Johnstone EB, Sharp HT, et al. Pain typology and incident endometriosis. Hum Reprod. 2015;30(10):2427–38.
doi: 10.1093/humrep/dev147
pubmed: 26269529
pmcid: 4573450
Rocha TP, Andres MP, Carmona F, Baracat EC, Abrão MS. Deep endometriosis: the involvement of multiple pelvic compartments is associated with more severe pain symptoms and infertility. Reprod Sci. 2022.
Scholl B, Bersinger NA, Kuhn A, Mueller MD. Correlation between symptoms of pain and peritoneal fluid inflammatory cytokine concentrations in endometriosis. Gynecol Endocrinol. 2009;25(11):701–6.
doi: 10.3109/09513590903159680
pubmed: 19903048
Da Broi MG, Navarro PA. Oxidative stress and oocyte quality: ethiopathogenic mechanisms of minimal/mild endometriosis-related infertility. Cell Tissue Res. 2016;364(1):1–7.
doi: 10.1007/s00441-015-2339-9
pubmed: 26685866
Opøien HK, Fedorcsak P, Polec A, Stensen MH, Åbyholm T, Tanbo T. Do endometriomas induce an inflammatory reaction in nearby follicles? Hum Reprod. 2013;28(7):1837–45.
doi: 10.1093/humrep/det087
pubmed: 23543385
La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Artenisio AC, et al. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update. 2010;16(2):113–30.
doi: 10.1093/humupd/dmp036
pubmed: 19793843
Garavaglia E, Sala C, Taccagni G, Traglia M, Barbieri C, Ferrari S, et al. Fertility preservation in endometriosis patients: anti-Müllerian hormone is a reliable marker of the ovarian follicle density. Front Surg. 2017;4:40.
doi: 10.3389/fsurg.2017.00040
pubmed: 28791295
pmcid: 5524724
Cobo A, Garcia-Velasco JA, Coello A, Domingo J, Pellicer A, Remohi J. Oocyte vitrification as an efficient option for elective fertility preservation. Fertil Steril. 2016;105(3):755–64 e8.
doi: 10.1016/j.fertnstert.2015.11.027
pubmed: 26688429
Bakkensen JB, Flannagan KSJ, Mumford SL, Hutchinson AP, Cheung EO, Moreno PI, et al. A SART data cost-effectiveness analysis of planned oocyte cryopreservation versus in vitro fertilization with preimplantation genetic testing for aneuploidy considering ideal family size. Fertil Steril. 2022;118(5):875–84.
doi: 10.1016/j.fertnstert.2022.07.022
pubmed: 36175208
Hans Evers JL. Is adolescent endometriosis a progressive disease that needs to be diagnosed and treated? Hum Reprod. 2013;28(8):2023.
doi: 10.1093/humrep/det298
pubmed: 23861497
Fedele L, Bianchi S, Zanconato G, Raffaelli R, Berlanda N. Is rectovaginal endometriosis a progressive disease? Am J Obstet Gynecol. 2004;191(5):1539–42.
doi: 10.1016/j.ajog.2004.06.104
pubmed: 15547522
Kasapoglu I, Ata B, Uyaniklar O, Seyhan A, Orhan A, Yildiz Oguz S, et al. Endometrioma-related reduction in ovarian reserve (ERROR): a prospective longitudinal study. Fertil Steril. 2018;110(1):122–7.
doi: 10.1016/j.fertnstert.2018.03.015
pubmed: 29935810
Practice Committee of the American Society for Reproductive Medicine. Comparison of pregnancy rates for poor responders using IVF with mild ovarian stimulation versus conventional IVF: a guideline. Fertil Steril 2018;109(6):993-9.